400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / Nucleoside Antimetabolite/Analog / Guadecitabine/SGI-110游离态
CAS No.: 929901-49-5
Synonyms: SGI-110;S110
Guadecitabine, aslo known as SGI-110, is a dinucleotide antimetabolite of a decitabine linked via phosphodiester bond to a guanosine, with potential antineoplastic activity.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00409006 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | China ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Collapse << |
NCT00409006 | - | - | Completed | - | - |
NCT02878785 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Recruiting | December 2022 | United States, Maryland ... more >> University of Maryland Greenebaum Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Sunita Philip, MPH, CCRP 410-328-8199 sphilip1@umm.edu Contact: Gary Saum 410-328-1180 gary.saum@umm.edu Principal Investigator: Maria Baer, MD Collapse << |
实验方案
技术信息
CAS号 | 929901-49-5 | 储存条件 |
|
|
分子式 | C18H24N9O10P | 运输 | 蓝冰 | |
分子量 | 557.41 | 别名 | SGI-110;S110 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00409006 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | China ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Collapse << |
NCT00409006 | - | - | Completed | - | - |
NCT02878785 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Recruiting | December 2022 | United States, Maryland ... more >> University of Maryland Greenebaum Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Sunita Philip, MPH, CCRP 410-328-8199 sphilip1@umm.edu Contact: Gary Saum 410-328-1180 gary.saum@umm.edu Principal Investigator: Maria Baer, MD Collapse << |
NCT01966289 | Metastatic Colorectal Cancer | Phase 1 | Active, not recruiting | December 2019 | United States, Maryland ... more >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Collapse << |
NCT03075826 | Myeloproliferative Neoplasms | Phase 2 | Recruiting | December 2019 | United States, New York ... more >> New York Weill Cornell Cancer Center at Cornell University Recruiting New York, New York, United States, 10021 Contact: Tania Curcio, NP 212-746-2571 tjc9003@med.cornell.edu Collapse << |
NCT02892318 | Acute Myeloid Leukemia | Phase 1 | Suspended(Study enrollment on ... more >>hold to evaluate safety and efficacy data.) Collapse << | January 31, 2019 | United States, California ... more >> City of Hope Duarte, California, United States, 91010 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, New York The NewYork-Presbyterian Hospital Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Wisconsin The University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States, 53705 Collapse << |
NCT02197676 | MDS | Phase 2 | Completed | - | France ... more >> CH Angers Angers, France, 49 000 CH Avignon Avignon, France, 84000 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93 000 CHU Clémenceau Caen, France, 14033 CHU Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 Centre Hospitalier du Mans Le Mans, France, 72000 CHRU Limoges Limoges, France, 87046 CH Lyon Sud Lyon, France, 69495 Hôpital Paoli Calmettes Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 Clinique Beausoleil (Montpellier) Montpellier, France, 34000 CHU de nantes Nantes, France, 44093 Centre Catherine de Sienne (Nantes) Nantes, France, 44277 CHU de Nice - Hopital de l'Archet 1 Nice, France, 06 202 CHR Orléans Orléans, France, 45000 Hopital St Louis T4 Paris, France, 75475 Centre Hospitalier Joffre Perpignan, France, 66046 CHU de Haut-Lévèque Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86000 Centre Hospitalier de la région d'Annecy Pringy, France, 74374 Centre Henri Becquerel Rouen, France, 76038 Chu Purpan Toulouse, France, 31059 Hopital Purpan Service d'Hématologie Clinique Toulouse, France CHU Bretonneau Tours, France, 37044 CHU Brabois Vandœuvre-lès-Nancy, France, 54511 Collapse << |
NCT02293993 | Acute Myeloid Leukemia | Phase 1 | Active, not recruiting | December 2019 | Japan ... more >> kinki Region Kyoto, Japan Kanto Region, Japan Kyusyu Region, Japan Collapse << |
NCT02684162 | Leukemia Myel... more >>oproliferative Diseases Collapse << | Phase 2 | Recruiting | June 2021 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT02348489 | Leukemia, Myeloid, Acute | Phase 3 | Completed | - | - |
NCT02096055 | Leukemia | Phase 2 | Active, not recruiting | April 2026 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT03206047 | Recurrent Fallopian Tube Carci... more >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse << | Phase 1 Phase 2 | Suspended(Pending outcome of t... more >>he DLT period) Collapse << | March 31, 2020 | United States, Arizona ... more >> University of Arizona Cancer Center-North Campus Tucson, Arizona, United States, 85719 The University of Arizona Medical Center-University Campus Tucson, Arizona, United States, 85724 United States, California University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 University of Chicago Medicine-Orland Park Orland Park, Illinois, United States, 60462 United States, Kansas University of Kansas Clinical Research Center Fairway, Kansas, United States, 66205 United States, Nebraska Nebraska Medicine-Village Pointe Omaha, Nebraska, United States, 68118 University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Collapse << |
NCT03085849 | Extensive-stage Small Cell Lun... more >>g Cancer Collapse << | Phase 1 | Completed | - | United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse << |
NCT03179943 | Urothelial Carcinoma | Phase 2 | Recruiting | July 2022 | United States, Pennsylvania ... more >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Elizabeth Plimack, MD 215-214-1515 Collapse << |
NCT03165721 | Paraganglioma ... more >> Gastrointestinal Stromal Tumors Carcinoma, Renal Cell Renal Neoplasms Pheochromocytoma Collapse << | Phase 2 | Recruiting | December 1, 2021 | United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse << |
NCT01752933 | Hepatocellular Carcinoma | Phase 2 | Completed | - | - |
NCT02998567 | Castration-Resistant Prostatic... more >> Cancer Non Small Cell Lung Cancer Collapse << | Phase 1 | Recruiting | December 2019 | United Kingdom ... more >> Rpyal Marsden Hospital Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Summen Chauhdry, BSc 02086421326 summen.chaudry@icr.ac.uk Principal Investigator: Johann de Bono, FRCP UCLH Recruiting London, United Kingdom, W1T 7HA Contact: James Wilton James.Wilton@uclh.nhs.uk Principal Investigator: Dionysis Papadatos-Pastos, FRCP Collapse << |
NCT01261312 | MDS CMML ... more >> AML Collapse << | Phase 1 Phase 2 | Completed | - | United States, Arizona ... more >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, California University of Southern California Los Angeles, California, United States, 90033 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists - South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists - North Saint Petersburg, Florida, United States, 33705 United States, Illinois University of Chicago Cancer Center Chicago, Illinois, United States, 60637 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Cornell University New York, New York, United States, 10021 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse << |
NCT03257761 | Extrahepatic Bile Duct Adenoca... more >>rcinoma, Biliary Type Gallbladder Adenocarcinoma, Biliary Type Metastatic Pancreatic Adenocarcinoma Recurrent Cholangiocarcinoma Recurrent Gallbladder Carcinoma Recurrent Hepatocellular Carcinoma Recurrent Intrahepatic Cholangiocarcinoma Recurrent Pancreatic Carcinoma Stage III Gallbladder Cancer AJCC V7 Stage III Hepatocellular Carcinoma AJCC v7 Stage III Intrahepatic Cholangiocarcinoma AJCC v7 Stage III Pancreatic Cancer AJCC v6 and v7 Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIB Gallbladder Cancer AJCC v7 Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IV Gallbladder Cancer AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IVA Gallbladder Cancer AJCC v7 Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVB Gallbladder Cancer AJCC v7 Stage IVB Hepatocellular Carcinoma AJCC v7 Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 Unresectable Gallbladder Carcinoma Unresectable Pancreatic Carcinoma Collapse << | Phase 1 | Recruiting | February 20, 2020 | United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Marile Garcia, RN 323-865-0967 Marile.GarciaLeiva@med.usc.edu Principal Investigator: Anthony El-Khoueiry Hoag Memorial Hospital Presbyterian Recruiting Newport Beach, California, United States, 92663 Contact: Alicia Bogardus, MA alicia.bogardus@hoag.org Principal Investigator: Diana Hanna, MD United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Candace Griffin 410-502-5568 cgriff22@jhmi.edu Principal Investigator: Nilofer S. Azad, MD Collapse << |
NCT03220477 | Lung Cancer | Phase 1 | Recruiting | July 2020 | United States, Maryland ... more >> John Hopkins Medical Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Jarushka Naidoo, M.B.B.Ch. 410-955-8866 Jhcccro@jhmi.edu Principal Investigator: Jarushka Naidoo, M.B.B.Ch. United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Matthew Hellmann, MD 646-888-4863 Contact: Charles Rudin, MD, PhD 646-888-4527 Principal Investigator: Matthew Hellmann, MD United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Hossein Borghaei, MS, DO 888-369-2427 Collapse << |
NCT02608437 | Metastatic Melanoma | Phase 1 | Unknown | October 2018 | Italy ... more >> Medical Oncology and Immunotherapy Unit, University Hospital of Siena Recruiting Siena, Italy, 53100 Contact: Anna Maria Di Giacomo, PhD, MD +390577586305 a.m.digiacomo@ao-siena.toscana.it Contact: Giovanni Amato, PhD +390577586326 dataman.immonco@ao-siena.toscana.it Collapse << |
NCT02131597 | High Risk Myelodysplastic Synd... more >>rome Collapse << | Phase 2 | Recruiting | November 1, 2019 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Guillermo Garcia-Manero 713-745-3428 ggarciam@mdanderson.org Principal Investigator: Guillermo Garcia-Manero Collapse << |
NCT03454984 | Myelodysplastic Syndromes ... more >> Acute Myeloid Leukemia Collapse << | Phase 2 | Not yet recruiting | March 2022 | France ... more >> CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sylvain THEPOT, md 33241354466 sylvain.thepot@chu-angers.fr Principal Investigator: Sylvain THEPOT, md CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Benoit DE RENZIS, MD 33473750065 bderenzis@chu-clermontferrand.fr Principal Investigator: Benoit DE RENZIS, MD Hôpital St Vincent de Paul Not yet recruiting Lille, France, 59020 Contact: Christian ROSE, prof 33320874532 Rose.Christian@ghicl.net Principal Investigator: Christian ROSE, prof CHU Nantes Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, MD 33240083333 pierre.peterlin@chu-nantes.fr Principal Investigator: Pierre PETERLIN, MD Hôpital Archet 1 Not yet recruiting Nice, France, 06200 Contact: Thomas CLUZEAU, Prof 33492035844 cluzeau.t@chu-nice.fr Hôpital St Louis Not yet recruiting Paris, France, 75010 Contact: Marie Robin, MD 33142499660 marie.robin@aphp.fr Principal Investigator: Marie Robin, MD Hôpital Pitié-Salpêtrière Paris, France, 75013 Hôpital Necker Not yet recruiting Paris, France, 75743 Contact: Felipe SUAREZ, MD 33144495368 felipe.suarez@aphp.fr Principal Investigator: Felipe SUAREZ, MD CHU de Haut-Lévèque Not yet recruiting Pessac, France, 33604 Contact: Sophie DIMICOLI-SALAZAR, md 33557656511 sophie.dimicoli-salazar@chu-bordeaux.fr Principal Investigator: Sophie DIMICOLI-SALAZAR, MD Centre Hospitalier Lyon-Sud Not yet recruiting Pierre-Bénite, France, 69495 Contact: Eric WATTEL, Prof 33478862205 eric.wattel@chu-lyon.fr Principal Investigator: Eric WATTEL, Prof CHU Toulouse - IUCT Oncopole Not yet recruiting Toulouse, France, 31059 Contact: Odile BEYNE-RAUZY, Prof 33531156248 beynerauzy.odile@iuct-oncopole.fr Principal Investigator: Odile BEYNE-RAUZY, Prof CHU Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Agnes GUERCI-BRESLER, md 33383153281 a.guerci@chru-nancy.fr Principal Investigator: Agnes GUERCI-BRESLER, md Collapse << |
NCT02935361 | Chronic Myelomonocytic Leukemi... more >>a Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Collapse << | Phase 1 Phase 2 | Recruiting | November 2, 2021 | United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Casey L. O'Connell 323-865-3950 coconnel@usc.edu Principal Investigator: Casey L. O'Connell United States, Maryland University of Maryland Medical Center Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Maria R. Baer MBaer@umm.edu Principal Investigator: Maria R. Baer United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patricia L. Kropf, MD 215-214-3119 Patricia.Kropf@tuhs.temple.edu Contact: Lilanee Chanyothi, RN 215-214-3035 Lilanee.Chanyothi@tuhs.temple.edu Principal Investigator: Patricia L. Kropf, MD Temple University Hospital Not yet recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Patricia L. Kropf Patricia.Kropf@tuhs.temple.edu Principal Investigator: Patricia L. Kropf Collapse << |
NCT01696032 | Ovarian Cancer | Phase 2 | Completed | - | - |
NCT03308396 | Advanced Kidney Cancer ... more >> Kidney Cancer Clear Cell Renal Cell Carcinoma Collapse << | Phase 1 Phase 2 | Recruiting | December 1, 2020 | United States, Illinois ... more >> Univerisity of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Erin Vidra 312-996-7902 evidra@uic.edu Principal Investigator: David Peace, MD United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Ajjai Alva, M.D. 734-936-0091 ajjai@umich.edu Contact: Carolina Fernandez-Castillo 734-763-8373 cefernan@med.umich.edu United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Daniel Bell 732-235-9850 dwb90@cinj.rutgers.edu Principal Investigator: Eric Singer, MD Collapse << |
NCT02901899 | Recurrent Fallopian Tube Carci... more >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Collapse << | Phase 2 | Recruiting | March 2020 | United States, Illinois ... more >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Daniela E. Matei 312-472-4684 daniela.matei@northwestern.edu Principal Investigator: Daniela E. Matei, MD Sub-Investigator: Emma Barber, MD Sub-Investigator: Shohreh Shahabi, MD Sub-Investigator: Wilberto Nieves-Neira, MD Sub-Investigator: John Lurian, MD The University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Gini Fleming, MD 773-702-6712 Principal Investigator: Gini Fleming, MD Northwestern Lake Forest Hospital Recruiting Lake Forest, Illinois, United States, 60045 Contact: Valerine Nelson, MD 312-695-6180 Contact: Alok Pant, MD (847)582-2134 Sub-Investigator: Valerine Nelson, MD Sub-Investigator: Alok Pant, MD Collapse << |
NCT02429466 | Germ Cell Tumor ... more >> Testis Cancer Testicular Cancer Collapse << | Phase 1 | Suspended | December 31, 2019 | United States, Indiana ... more >> Indiana University Hospital Indianapolis, Indiana, United States, 46202 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Collapse << |
NCT03576963 | Colorectal Adenocarcinoma ... more >> CpG Island Methylator Phenotype Metastatic Microsatellite Stable Colorectal Carcinoma Refractory Colorectal Carcinoma Stage IV Colorectal Cancer AJCC v8 Stage IVA Colorectal Cancer AJCC v8 Stage IVB Colorectal Cancer AJCC v8 Stage IVC Colorectal Cancer AJCC v8 Collapse << | Phase 1 Phase 2 | Not yet recruiting | February 25, 2022 | United States, California ... more >> USC / Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90033 Contact: Dana Agafitei 323-865-0467 Raluca.Agafitei@med.usc.edu Principal Investigator: Heinz-Josef Lenz, MD Hoag Memorial Hospital Presbyterian Not yet recruiting Newport Beach, California, United States, 92658 Contact: Alicia Bogardus, MA 949-764-6755 Alicia.bogardus@hoag.org Principal Investigator: Diana Hanna, MD Collapse << |
NCT02907359 | Myelodysplastic Syndromes ... more >> Leukemia, Myelomonocytic, Chronic Collapse << | Phase 3 | Recruiting | December 2019 | - |
NCT03603964 | Acute Myeloid Leukemia ... more >> Myeloid Dysplastic Syndrome Collapse << | Phase 2 | Not yet recruiting | July 1, 2020 | United States, New York ... more >> Roswell Park Enrolling by invitation Buffalo, New York, United States, 14263 United States, North Carolina Duke Cancer Center Enrolling by invitation Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Enrolling by invitation Columbus, Ohio, United States, 43210 United States, Pennsylvania Temple University Enrolling by invitation Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Center for Blood Cancers Enrolling by invitation Nashville, Tennessee, United States, 37203 Austria Medizinische Universität Graz Enrolling by invitation Graz, Styria, Austria Canada, Ontario The Ottawa Hospital - General Enrolling by invitation Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Center Enrolling by invitation Toronto, Ontario, Canada, M5G 2M9 Denmark Rigshospitalet-Copenhagen University Hospital Enrolling by invitation Copenhagen, Denmark Italy Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria Enrolling by invitation Alessandria, Italy Azienda Ospedaliera Universitaria San Martino Enrolling by invitation Genova, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Enrolling by invitation Milano, Italy Azienda Ospedaliero Universitaria S. Maria della Misericordia di Udine Enrolling by invitation Udine, Italy Japan Tokai University Hospital Enrolling by invitation Isehara-shi, Japan, 259-1193 Japanese Red Cross Kyoto Daini Hospital Enrolling by invitation Kyoto-shi, Japan, 602-8026 Saga University Hospital Enrolling by invitation Saga-shi, Japan, 849-8501 Korea, Republic of Severance Hospital, Yonsei University Health System Enrolling by invitation Seoul, Korea, Republic of, 03722 Ulsan University Hospital Enrolling by invitation Ulsan, Korea, Republic of, 44033 Spain Hospital Universitario 12 de Octubre Enrolling by invitation Madrid, Spain Taiwan Mackay Memorial Hospital Enrolling by invitation Taipei, Taiwan National Taiwan University Hospital Enrolling by invitation Taipei, Taiwan Collapse << |
NCT02920008 | Acute Myeloid Leukemia | Phase 3 | Active, not recruiting | December 2019 | - |
NCT01896856 | Previously Treated Metastatic ... more >>Colorectal Cancer Collapse << | Phase 2 | Recruiting | September 2019 | United States, California ... more >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Anthony El-Khoueiry, MD 323-865-3967 elkhouei@med.usc.edu United States, Maryland Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ellen Lilly-Foreman, RN 443-287-4961 lillyel@jhmi.edu Contact: Tearra Miles tlawre18@jhmi.edu Principal Investigator: Nilo Azad, MD United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Derek Alexander 646-888-1381 alexandd@mskcc.org Principal Investigator: Andrea Cercek, MD Netherlands VU Medisch Centrum Recruiting Amsterdam, Netherlands, 1081 HV Contact: Henk Verheul, MD h.verheul@vumc.nl Contact: Elske Gootjes, MD e.gootjes@vumc.nl Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网